Skip navigationU.S. Food and Drug Administration Center for Drug Evaluation and Research

CDER - Center for Drug Evaluation and Research Logo

Office of Generic Drugs

Reference Listed Drug Labeling and Efficacy Supplements Approved in October 2002
Click on appropriate hyperlink below to view available source document in PDF format

Approval

Date

Product Name

Source Documents

Active Ingredient(s)/Dosage Form

Document ID No.
Oct 1 THYROLAR-3 letter label liotrix tablets 16-807 SLR 025
Oct 1 VUMON letter label teniposide for injection 20-119 SLR 004
Oct 2 PAXIL letter label paroxetine HCl tablets 20-031 SE8 035
Oct 2 WELLBUTRIN letter label bupropion HCl tablets 18-644 SLR 024
Oct 2 WELLBUTRIN SR letter label bupropion HCl extended-release tablets 20-358 SLR 024
Oct 2 ZAGAM letter label sparfooxacin tablets 20-677 SLR 004
Oct 2 ZIAGEN letter label abacavir sulfate tablets 20-977 SLR 007
Oct 2 ZIAGEN letter label abacavir sulfateoral solution 20-978 SLR 008
Oct 3 LARIAM letter label mefloquine HCl tablets 19-591 SLR 020
Oct 4 PROSTEP letter label nicotine transdermal system 19-983 SLR 017
Oct 7 ARIMIDEX letter label anastrozole tablets 20-541 SLR 005
Oct 7 LITHOBID letter label lithium carbonate extended-release tablets 18-027 SLR 049
Oct 7 ZONEGRAN letter label zonisamide capsules 20-789 SLR 005
Oct 8 COMBIVIR letter label lamivudine/zidovudine tablets 20-857 SLR 012
Oct 8 EPIVIR letter label lamivudine tablets 20-564 SLR 014
Oct 8 EPIVIR letter label lamivudine oral solution 20-596 SLR 015
Oct 8 ETHRANE letter label ethrane liquid for inhalation 17-087 SLR 045
Oct 8 TRIZIVIR letter label abacavir/lamivudine/zidovudine tablets 21-205 SLR 007
Oct 9 AVODART letter label dutasteride capsules 21-319 SE1 001
Oct 9 ZOMIG letter label zolmitriptan tablets 20-768 SLR 010
Oct 9 ZOMIG-ZMT letter label zolmitriptan orally disintegrating tablets 21-231 SLR 003
Oct 10 DARAPRIM

   

label pyrimethamine tablets 08-578 SLR 015
Oct 16 VIDEX EC letter label didanosine EC tablets 21-183 SLR 006
Oct 16 ZITHROMAX letter label azithromycin single dose pack 50-693 SLR 005
Oct 16 ZITHROMAX letter label azithromycin for injection 50-733 SLR 006
Oct 16 ZITHROMAX letter label azithromycin tablets 50-730 SLR 007
Oct 16 ZITHROMAX letter label azithromycin capsules 50-670 SLR 017
Oct 16 ZITHROMAX letter label azithromycin oral suspension 50-710 SLR 007
Oct 16 ZITHROMAX TRI-PAK letter label azithromycin tablets 50-784 SLR 002
Oct 17 TEQUIN letter label gatifloxacin injection 21-062 SLR 017
Oct 17 TEQUIN letter label gatifloxacin tablets 21-061 SLR 016
Oct 18 LIPITOR letter label atorvastatin tablets 20-702 SE5 033
Oct 18 ZOCOR letter label simvastatin tablets 19-766 SE5 056
Oct 21 PRANDIN letter label repaglinide tablets 20-741 SE1 013
Oct 21 ZYRTEC letter label cetirizine tablets 20-346 SE5 008
Oct 21 ZYRTEC letter label cetirizine syrup 19-835 SE5 015
Oct 22 ANDROGEL letter label testosterone gel 21-015 SLR 004
Oct 22 EFFEXOR XR letter label venlafaxine HCl extended-release capsules 20-699 SLR 029
Oct 22 WELLBUTRIN letter label bupropion HCl tablets 18-644 SLR 026
Oct 22 WELLBUTRIN SR letter label bupropion HCl extended-release tablets 20-358 SLR 029
Oct 25 BENICAR letter label olmesartan medoxomil tablets 21-286 SLR 001
Oct 28 COSMEGEN letter label dactinomycin injection 50-682 SLR 019
Oct 28 PROTONIX letter label pantoprazole delayed-release tablets 20-987 SLR 013
Oct 28 PROTONIX IV letter label pantoprazole injection 20-988 SLR 012
Oct 29 BUMEX letter label bumetanide tablets 18-225 SLR 019
Oct 29 BUMEX letter label bumetanide injection 18-226 SLR 025
Oct 29 MYKROX letter label metolazone tablets 19-532 SLR 015
Oct 29 PRAVACHOL letter label pravastatin tablets 19-898 SE5 052
Oct 29 PRECOSE letter label acarbose tablets 20-482 SLR 011
Oct 29 ZAROXOLYN letter label metolazone tablets 17-386 SLR 034
Oct 30 LEVAQUIN letter label levofloxacin tablets 20-634 SE1 025
Oct 30 LEVAQUIN letter label levofloxacin injection 20-635 SE1 022
Oct 31 ZINECARD letter label dexrazoxane injection 20-212 SE7 006

 

totop.gif (1525 bytes) Back to Top

Back Labeling Review Branch Page

FDA/Center for Drug Evaluation and Research
Last Updated: January 18, 2006
Originator: OTCOM/DLIS
HTML by JFG